Innovation in Drug Delivery The future of nanotechnology and non-invasive protein delivery

Drug delivery is one of the most dynamic and fast growing sectors of the pharmaceutical industry; the high level of innovation in this sector is evolving at a fast pace with products such as Pfizer’s inhaled insulin, Exubera, gaining US approval in January 2006. ‘Innovation in Drug Delivery’ provides an in-depth examination of product launches and pipeline drugs with novel drug delivery mechanisms set to revolutionize the market, such as products using ALZA Corporation’s E-TRANS and Altea’s PassPort patch transdermal technologies. This report will enable you to evaluate key marketed drugs, including Emend and Megace, and gain an insight into novel pipeline products to anticipate upcoming product launches and position yourself for success. Use this report to understand how nanotechnology and other key technologies are changing drug delivery and how these can be implemented into your R&D process. Assess the impact of innovation in therapy areas including oncology, diabetes and infectious diseases and identify future opportunities for market growth.

Published: November 2006
Table of Contents
Table of Contents (PDF)
Price: $2,875.00 / GBP1,437.50